Lobe Sciences Ltd.: Lobe Sciences Provides an Update to Clinical Development Plans for Its Proprietary Psilocin Product, L-130
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering